TASHKENT, Uzbekistan, February 3. Uzbekistan
and the European Union discussed issues related to the
implementation of investment projects in the pharmaceutical
industry, including the localization of production, Trend reports via the
Pharmaceutical Industry Development Agency of Uzbekistan.
The discussion took place during a meeting between Abdulla
Azizov, Director of the Pharmaceutical Industry Development Agency,
Toivo Klaar, Ambassador of the European Union to Uzbekistan, and
Akmal Rustamov, Project Manager.
During the meeting, the parties exchanged views on the European
Union’s research and innovation program Horizon Europe, including
its potential application in Uzbekistan’s pharmaceutical sector,
future cooperation prospects, and expected outcomes.
A presentation was also delivered on the opportunities offered
by the Tashkent Pharma Park innovative pharmaceutical cluster,
highlighting its modern scientific, research, and manufacturing
infrastructure.
At the conclusion of the meeting, the parties expressed interest
in developing joint investment and research projects, strengthening
practical cooperation, and implementing joint initiatives in
science, education, and innovation within the pharmaceutical
sector.
Meanwhile, in October 2025, Uzbekistan and the European Union
signed the Enhanced Partnership and Cooperation Agreement (EPCA),
which provides an expanded framework for political dialogue and
economic cooperation. The agreement aims to deepen EU engagement
with Uzbekistan, including cooperation in industry, innovation, and
investment-oriented sectors such as pharmaceuticals.
Stay up-to-date with more news on Trend News
Agency's WhatsApp channel
